Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) insider Brian Daniel Webster sold 15,000 shares of the company's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $27.48, for a total value of $412,200.00. Following the completion of the transaction, the insider directly owned 460,215 shares in the company, valued at $12,646,708.20. This represents a 3.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Brian Daniel Webster also recently made the following trade(s):
- On Tuesday, August 4th, Brian Daniel Webster sold 51,900 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $24.52, for a total value of $1,272,588.00.
- On Monday, August 3rd, Brian Daniel Webster sold 13,017 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $23.92, for a total value of $311,366.64.
- On Friday, July 31st, Brian Daniel Webster sold 8,948 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.60, for a total value of $202,224.80.
- On Thursday, July 30th, Brian Daniel Webster sold 7,857 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $22.72, for a total value of $178,511.04.
- On Monday, June 15th, Brian Daniel Webster sold 15,000 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $20.81, for a total value of $312,150.00.
Kestra Medical Technologies Price Performance
KMTS stock opened at $27.93 on Wednesday. The company has a current ratio of 4.41, a quick ratio of 4.41 and a debt-to-equity ratio of 0.16. Kestra Medical Technologies, Ltd. has a one year low of $15.42 and a one year high of $30.00. The firm has a market capitalization of $1.64 billion, a PE ratio of -11.54 and a beta of 0.58. The firm has a 50-day moving average of $24.13 and a two-hundred day moving average of $22.74.
Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last released its earnings results on Tuesday, July 14th. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.59) by ($0.08). Kestra Medical Technologies had a negative return on equity of 57.38% and a negative net margin of 138.35%.The firm had revenue of $28.64 million during the quarter. On average, analysts forecast that Kestra Medical Technologies, Ltd. will post -2.29 earnings per share for the current year.
Analyst Ratings Changes
Several brokerages have issued reports on KMTS. Weiss Ratings raised shares of Kestra Medical Technologies from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Tuesday, August 11th. Wolfe Research set a $30.00 target price on Kestra Medical Technologies in a research report on Wednesday, July 15th. Wall Street Zen upgraded Kestra Medical Technologies from a "sell" rating to a "hold" rating in a report on Saturday, August 8th. JPMorgan Chase & Co. assumed coverage on Kestra Medical Technologies in a research note on Monday, August 10th. They issued an "overweight" rating and a $30.00 price objective for the company. Finally, BTIG Research raised their price objective on Kestra Medical Technologies from $30.00 to $32.00 and gave the stock a "buy" rating in a research report on Wednesday, July 15th. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Kestra Medical Technologies has an average rating of "Hold" and an average price target of $28.14.
Get Our Latest Report on Kestra Medical Technologies
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System lifted its position in Kestra Medical Technologies by 39.2% in the 1st quarter. California State Teachers Retirement System now owns 27,835 shares of the company's stock worth $555,000 after buying an additional 7,844 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Kestra Medical Technologies by 6.6% during the 1st quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company's stock valued at $1,844,000 after acquiring an additional 5,731 shares in the last quarter. Quantinno Capital Management LP acquired a new position in shares of Kestra Medical Technologies in the first quarter worth $431,000. Sei Investments Co. raised its holdings in shares of Kestra Medical Technologies by 22.6% during the first quarter. Sei Investments Co. now owns 237,116 shares of the company's stock worth $4,726,000 after acquiring an additional 43,753 shares in the last quarter. Finally, Spartan Wealth Advisory Services LLC acquired a new stake in Kestra Medical Technologies during the first quarter valued at $603,000.
Kestra Medical Technologies Company Profile
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator (“WCD”) used to protect patients at an elevated risk of sudden cardiac arrest (“SCA”), a major public health problem that accounts for approximately 50% of all cardiovascular deaths in the U.S.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
